| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Lesueur Daniel serves as a Chief Operating Officer at HCAT. Across recent SEC filings that breaks down to 0 buys and 12 sells. Those positions are worth an estimated $667K at current prices.
Historically, Lesueur Daniel's trades have earned a strong insider score of 83/100 across 12 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +56.3%.
The biggest single holding is HCAT (~$667K) as Chief Operating Officer. The recent filings there lean toward selling, a net 101,406 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 3, 2024 | HCAT Health Catalyst, Inc. | Chief Operating Officer | Sell | 5,208 | $6.15 | $32,048.99 | -3.2% | +30.3% | -34.3% | |
| Jun 6, 2024 | HCAT Health Catalyst, Inc. | Chief Operating Officer | Sell | 11,923 | $6.72 | $80,064.14 | -6.9% | +13.9% | -38.1% |